Expression, subcellular localization, and regulation of sigma receptor in retinal Müller cells

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 12, 2006, Pages 5576-5582

  Jiang, Guoliang ^a   Mysona, Barbara ^a   Dun, Ying ^a   Gnana Prakasam, Jaya P ^a   Pabla, Navjotsin ^a   Li, Weiguo ^a   Dong, Zheng ^a   Ganapathy, Vadivel ^a   Smith, Sylvia B ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PENTAZOCINE; REACTIVE OXYGEN METABOLITE; SIGMA OPIATE RECEPTOR; LIGAND; MESSENGER RNA; SIGMA 1 OPIATE RECEPTOR; SIGMA-1 RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CELL LINE; CELL MEMBRANE; CELL NUCLEUS; COMPETITIVE INHIBITION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DATA ANALYSIS; DIABETIC RETINOPATHY; ENDOPLASMIC RETICULUM; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; INCUBATION TIME; LIGAND BINDING; MOUSE; MUELLER CELL; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA CELL; RETINA DEGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BINDING COMPETITION; C57BL MOUSE; CULTURE TECHNIQUE; DRUG EFFECT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; GLIA; MALE; METABOLISM; PHYSIOLOGY; RETINA; WESTERN BLOTTING;

ANIMALS; BINDING, COMPETITIVE; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION; LIGANDS; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; NEUROGLIA; OXIDATIVE STRESS; PENTAZOCINE; RECEPTORS, SIGMA; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34248198347     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0608     Document Type: Article

References (46)

1. Monnet FP, Maurice T. The sigma-1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological and behavioral aspects. J Pharmacol Sci. 2006;100:93-118.
2. Quirion R, Bowen WD, Itzhak Y, et al. A proposal for the classification of sigma binding sites. Trends Pharmacol Sci. 1992;13:85-86.
3. Hanner M, Moebius FF, Flandorfer A, et al. Purification, molecular cloning, and expression of the mammalian sigma 1-binding site. Proc Natl Acad Sci USA. 1996;93:8072-8077.
4. Kekuda R, Prasad PD, Fei YJ, Leibach FH, Ganapathy V. Cloning and functional expression of the human type 1 sigma receptor (hσ-R1). Biochem Biophys Res Commun. 1996;229:553-558.
5. Prasad PD, Li HW, Fei YJ, et al. Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 sigma receptor gene. J Neurochem. 1998;70:443-451.
6. Seth P, Leibach FH, Ganapathy V. Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor. Biochem Biophys Res Comm. 1997;241:535-540.
7. Seth P, Fei Y-J, Li HW, Huang W, Leibach FH, Ganapathy V. Cloning and functional characterization σ from rat brain. J Neurochem. 1998;70:922-931.
8. Aydar E, Palmer C, Klachko V, Jackson M. Sigma receptor as a ligand-modulated auxiliary potassium channel subunit. Neuron. 2002;34:399-410.
9. Maurice T, Urani A, Phan VL, Romieu P. The interaction between neuroactive steroids and the sigma 1 receptor function: behavioral consequences and therapeutic opportunities. Brain Res Brain Res Rev. 2001;37:116-132.
10. Lobner D, Lipton P. σLigands and non-competitive NMDA antagonists inhibit glutamate release during cerebral ischemia. Neurosci Lett. 1990;117:169-174.
11. Lockhart BP, Soulard P, Benicourt C, Privat A, Junien J-L. Distinct neuroprotective profiles for σ-ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res. 1995;675:110-120.
12. DeCoster MA, Klette KL, Knight KS, Tortella SC. σ Receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res. 1995;671:45-53.
13. Klette KL, DeCoster MA, Moreton JE, Tortella FC. Role of calcium in sigma-mediated neuroprotection in rat primary cortical cultures. Brain Res. 1995;704:31-41.
14. Bhardwaj A, Sawada M, London ED, Koehler RC, Traystman RJ, Kirsch JR. Potent σ1 -receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo. Stroke. 1998;29:2404-2411.
15. Carter C, Benavides J, Legendre P, et al. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents, II: evidence for N-methyl-D-aspartate σ-receptor antagonist properties. J Pharmacol Exp Ther. 1988;247:1222-1232.
16. Yamamoto H, Yamamoto T, Sagi N, et al. Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via sigma 1 site. J Neurosci. 1995;15:731-736.
17. Goyagi T, Goto S, Bhardwaj A, Dawson VL, Hurn PD, Kirsch JR. Neuroprotective effect of sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production. Stroke. 2001;32:1613-1620.
18. Bucolo C, Drago F. Effects of neurosteroids on ischemia-reperfusion injury in the rat retina: role of sigmal recognition sites. Eur J Pharmacol. 2004;498:111-114.
19. Campana G, Bucolo C, Murari G, Spampinato S. Ocular hypotensive action of topical flunarizine in the rabbit: role of sigma 1 recognition sites. J Pharmacol Exp Ther. 2002;303:1086-1094.
20. Bucolo C, Campana G, Di Toro R, Cacciaguerra S, Spampinato S. Sigmal recognition sites in rabbit iris-ciliary body: topical sigma1-site agonists lower intraocular pressure. J Pharmacol Exp Ther. 1999;289:1362-1369.
21. Senda T, Mita S, Kaneda K, Kikuchi M, Akaike A. Effect of SA4503, a novel sigma1 receptor agonist, against glutamate neurotoxicity in cultured rat retinal neurons. Eur J Pharmacol. 1998;342:105-111.
22. Senda T, Matsuno K, Mita S. The presence of sigma receptor subtypes in bovine retinal membranes. Exp Eye Res. 1997;64:857-860.
23. Ola MS, Moore PM, El-Sherbeny A, et al. Expression pattern of sigma receptor 1 mRNA and protein in mammalian retina. Brain Res Mol Brain Res. 2001;95:86-95.
24. Ola MS, Martin PM, Maddox D, et al. Analysis of sigma receptor (σ R1) expression in retinal ganglion cells cultured under hyperglycemic conditions and in diabetic mice. Brain Res Mol Brain Res. 2002;107:97-107.
25. Martin PM, Ola MS, Agarwal N, Ganapathy V, Smith SB. The sigma receptor (σ-R) ligand (+)-pentazocine prevents retinal ganglion cell death induced in vitro by homocysteine and glutamate. Brain Res Mol Brain Res. 2004;123:66-75.
26. 3H]-1,3-di-o-tolyl-guanidine (DTG) in the rat glioma cell line C6-BU-1. Glia. 1992;6:258-263.
27. Palacios G, Muro A, Vela JM, et al. Immunohistochemical localization of the sigma1-receptor in oligodendrocytes in the rat central nervous system. Brain Res. 2003;961:92-99.
28. Palacios G, Muro A, Verdu E, Pumarola M, Vela JM. Immunohistochemical localization of the sigma1 receptor in Schwann cells of rat sciatic nerve. Brain Res. 2004;1007:65-70.
29. Hayashi T, Su TP. Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation. Proc Natl Acad Sci USA. 2004;101:14949-14954.
30. Bringmann A, Reichenbach A. Role of Müller cells in retinal degenerations. Front Biosci. 2001;6:77-92.
31. Umapathy NS, Li W, Mysona BA, Smith SB, Ganapathy V. Expression and function of glutamine transporters SN1 (SNAT3) and SN2 (SNAT5) in retinal Müller cells. Invest Ophthalmol Vis Sci. 2005; 46:3980-3987.
32. Hicks D, Courtois Y. The growth and behavior of rat retinal Müller cells in vitro, I: an improved method for isolation and culture. Exp Eye Res. 1990;51:119-129.
33. Sarthy VP, Brodjian SJ, Dutt K, Kennedy BN, French RP, Crabb JW. Establishment and characterization of a retinal Müller cell line. Invest Ophthalmol Vis Sci. 1998;39:212-216.
34. Krishnamoorthy RR, Agarwal P, Prasanna G, et al. Characterization of a transformed rat retinal ganglion cell line. Brain Res Mol Brain Res. 2001;86:1-12.
35. -) exchanger in cultured retinal ganglion cells and regulation by nitric oxide and oxidative stress. Cell Tiss Res. 2006; 324:189-202.
36. Ramamoorthy JD, Ramamoorthy S, Mahesh VB, Leibach FH, Ganapathy V. Cocaine-sensitive sigma-receptor and its interaction with steroid hormones in the human placental syncytiotrophoblast and in choriocarcinoma cells. Endocrinology. 1995;136:924-932.
37. 3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. J Pharmacol Exp Ther. 1982;223:284-290.
38. Cobos EJ, Baeyens JM, Del Pozo E. Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma 1 receptors of guinea pig brain. Synapse. 2005;55:192-195.
39. Goldstein IM, Ostwald P, Roth S. Nitric oxide: a review of its role in retinal function and disease. Vision Res. 1996;36:2979-2994.
40. Schmetterer L, Findl O, Fasching P, et al. Nitric oxide and ocular blood flow in patients with IDDM. Diabetes. 1997;46:653-658.
41. Du Y, Sarthy VP, Kern TS. Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. Am J Physiol Regul Integr Comp Physiol. 2004;287: R735-R741.
42. Yilmaz G, Esser P, Kociek N, Aydin P, Heimann K. Elevated vitreous nitric oxide levels in patients with proliferative diabetic retinopathy. Am J Ophthalmol. 2000;130:87-90.
43. Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350:48-58.
44. Levin LA, Gordon LK. Retinal ganglion cell disorders: types and treatments. Prog Retina Eye Res. 2002;21:465-484.
45. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci. 2004;45:3330-3336.
46. Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci. 2005;46:2210-2218.